Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors
Related Posts
Shannon EM, Chen L, Yuan A, Chary A, Gabrielian S, Eisenman DP, Washington DL. Extreme Heat, Social Factors, and Mortality Among California Veterans With Cardiometabolic[...]
Blanco LR, Choi A, Hays RD. Differences in Retirement Knowledge and Financial Preparedness between Hispanic and Non-Hispanic White Older Adults in the United States. Gerontologist.[...]
Binod M, Chang L, Hung MW, Dong TS, Kilpatrick LA, Tomasevic A, Choy M, Shin A, Mayer EA, Church A. Multi-omics analysis reveal clinical-gut-brain interactions[...]